These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Protective Role of Hepatocyte Cyclooxygenase-2 Expression Against Liver Ischemia-Reperfusion Injury in Mice. Motiño O; Francés DE; Casanova N; Fuertes-Agudo M; Cucarella C; Flores JM; Vallejo-Cremades MT; Olmedilla L; Pérez Peña J; Bañares R; Boscá L; Casado M; Martín-Sanz P Hepatology; 2019 Aug; 70(2):650-665. PubMed ID: 30155948 [TBL] [Abstract][Full Text] [Related]
6. Myeloid Deletion of Cdc42 Protects Liver From Hepatic Ischemia-Reperfusion Injury via Inhibiting Macrophage-Mediated Inflammation in Mice. He J; Tang MY; Liu LX; Kong CX; Chen W; Wang L; Zhi SB; Sun HW; Huang YC; Chen GY; Xin HB; Deng KY Cell Mol Gastroenterol Hepatol; 2024; 17(6):965-981. PubMed ID: 38342302 [TBL] [Abstract][Full Text] [Related]
7. C-C Chemokine Ligand-5 is critical for facilitating macrophage infiltration in the early phase of liver ischemia/reperfusion injury. Lee CM; Peng HH; Yang P; Liou JT; Liao CC; Day YJ Sci Rep; 2017 Jun; 7(1):3698. PubMed ID: 28623253 [TBL] [Abstract][Full Text] [Related]
9. Pretreatment with paricalcitol attenuates inflammation in ischemia-reperfusion injury via the up-regulation of cyclooxygenase-2 and prostaglandin E2. Hwang HS; Yang KJ; Park KC; Choi HS; Kim SH; Hong SY; Jeon BH; Chang YK; Park CW; Kim SY; Lee SJ; Yang CW Nephrol Dial Transplant; 2013 May; 28(5):1156-66. PubMed ID: 23229926 [TBL] [Abstract][Full Text] [Related]
10. Key m Zhang Y; Qi C; Guo Y; Li X; Zhu Z BMC Med Genomics; 2023 Dec; 16(1):314. PubMed ID: 38049811 [TBL] [Abstract][Full Text] [Related]
11. Nogo-B is a key mediator of hepatic ischemia and reperfusion injury. Rao J; Cheng F; Zhou H; Yang W; Qiu J; Yang C; Ni X; Yang S; Xia Y; Pan X; Zhang F; Lu L; Wang X Redox Biol; 2020 Oct; 37():101745. PubMed ID: 33099216 [TBL] [Abstract][Full Text] [Related]
12. Role of preferential cyclooxygenase-2 inhibition by meloxicam in ischemia/reperfusion injury of the rat liver. Tolba RH; Fet N; Yonezawa K; Taura K; Nakajima A; Hata K; Okamura Y; Uchinami H; Klinge U; Minor T; Yamaoka Y; Yamamoto Y Eur Surg Res; 2014; 53(1-4):11-24. PubMed ID: 24854565 [TBL] [Abstract][Full Text] [Related]
13. Tenascin-C: a novel mediator of hepatic ischemia and reperfusion injury. Kuriyama N; Duarte S; Hamada T; Busuttil RW; Coito AJ Hepatology; 2011 Dec; 54(6):2125-36. PubMed ID: 21898491 [TBL] [Abstract][Full Text] [Related]
14. Complement 5 Inhibition Ameliorates Hepatic Ischemia/reperfusion Injury in Mice, Dominantly via the C5a-mediated Cascade. Kusakabe J; Hata K; Tamaki I; Tajima T; Miyauchi H; Wang Y; Nigmet Y; Okamura Y; Kubota T; Tanaka H; Tsuruyama T; Uemoto S Transplantation; 2020 Oct; 104(10):2065-2077. PubMed ID: 32384381 [TBL] [Abstract][Full Text] [Related]
15. Activation of YAP attenuates hepatic damage and fibrosis in liver ischemia-reperfusion injury. Liu Y; Lu T; Zhang C; Xu J; Xue Z; Busuttil RW; Xu N; Xia Q; Kupiec-Weglinski JW; Ji H J Hepatol; 2019 Oct; 71(4):719-730. PubMed ID: 31201834 [TBL] [Abstract][Full Text] [Related]
16. Fibronectin-α4β1 interactions in hepatic cold ischemia and reperfusion injury: regulation of MMP-9 and MT1-MMP via the p38 MAPK pathway. Duarte S; Shen XD; Fondevila C; Busuttil RW; Coito AJ Am J Transplant; 2012 Oct; 12(10):2689-99. PubMed ID: 22812390 [TBL] [Abstract][Full Text] [Related]
17. The inhibition of aldose reductase attenuates hepatic ischemia-reperfusion injury through reducing inflammatory response. Li CX; Ng KT; Shao Y; Liu XB; Ling CC; Ma YY; Geng W; Qi X; Cheng Q; Chung SK; Lo CM; Man K Ann Surg; 2014 Aug; 260(2):317-28. PubMed ID: 24699020 [TBL] [Abstract][Full Text] [Related]
18. Cell-specific overactivation of nuclear erythroid 2 p45-related factor 2-mediated gene expression in myeloid cells decreases hepatic ischemia/reperfusion injury. Lee LY; Harberg C; Matkowskyj KA; Cook S; Roenneburg D; Werner S; Johnson DA; Johnson JA; Foley DP Liver Transpl; 2016 Aug; 22(8):1115-28. PubMed ID: 27113842 [TBL] [Abstract][Full Text] [Related]
19. Ischemia and reperfusion liver injury is reduced in the absence of Toll-like receptor 4. Ben-Ari Z; Avlas O; Fallach R; Schmilovitz-Weiss H; Chepurko Y; Pappo O; Hochhauser E Cell Physiol Biochem; 2012; 30(2):489-98. PubMed ID: 22797797 [TBL] [Abstract][Full Text] [Related]
20. Myeloid PTEN deficiency protects livers from ischemia reperfusion injury by facilitating M2 macrophage differentiation. Yue S; Rao J; Zhu J; Busuttil RW; Kupiec-Weglinski JW; Lu L; Wang X; Zhai Y J Immunol; 2014 Jun; 192(11):5343-5353. PubMed ID: 24771857 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]